Paolo Siviero

Member of Board of Directors and Series A Investor

Paolo is Head of Investments for Principia III, the first Italian VC and PE fund entirely dedicated to life sciences investments, and formerly Head of Strategy and Policy on Medical Products Area at AIFA (Italian regulator).  

At Agenzia Italiana del Farmaco (AIFA), Paolo was responsible for establishing prices and refundability of medicines, evaluating HTAs and checking pharmaceutical expenditures. Prior to joining AIFA, he was Chairman of MEDEV Group and a Board Member of the European Medicines Agency (EMA). Paolo has extensive experience investing in life sciences companies, including AnaBios, Enterome, and Ixaltis.

For more information about Principia, please visit their website: